How CBD Oil Can Heal Chronic Pain: A Doctor’s Observations

Can we legally buy and take in cannabis in France today? Yes and no. Yes, since the state has actually relaxed its regulations on CBD, including through the Minister of Health. And no, at the same time, since only products containing cannabidiol (CBD), an active substance that does not have the psychoactive results attributed to THC, are thought about legal. Let us analyze what is legal and what is not with regard to cannabis and CBD.

CBD is legal in France, but THC is not

Marijuana needs to not be confused with cannabidiol. Particularly considering that the second is legal in specific kinds in France … While the other is not! Because cannabidiol (understood by the acronym CBD stream) is just one of the many active substances from the hemp plant, which does not have the psychoactive results of its cousin THC – the one that makes you “stone”.

Simply put, what is generally called “cannabis”, which consists of high concentrations of THC (tetrahydrocannabinol) is still thought about a narcotic product. And therefore illegal in France as in numerous nations in the world. On the other hand, cannabis which provides pride of place to the cannabinoid referred to as cannabidiol, it is legal as long as its THC levels do not exceed 0.2%.

However, the legislation remains unclear in France on this subject. Currently, there is no law that makes it clear whether CBD is legal or not. Concretely, it is licensed for sale in the form of E-liquid, to be used in an e cigarette. But it is also found in other kinds (including oil or paste), without its purchase and usage being reprehensible … To attempt to make it simple, let’s say that connect CBD is not forbidden by French law, unlike THC

CBD vs THC.

Although CBD and THC are identical, they are very various. These are the best understood of the 500 cannabinoids found in hemp. And each has its specific results. THC is especially understood for its psychoactive properties: it triggers a modification in the state of consciousness by acting directly on the brain. By consuming cannabis abundant in THC, we “hover”: well-being, ecstasy, relaxation … But also red eyes, dilated students and, in some cases, anxiety and even fear.

CBD has nothing to do with it. It is not euphoric. It does not cause anxiety or anxiety attacks. On the contrary: cannabidiol is in the procedure of making its way by virtue of its beneficial healing results. CBD helps eliminate pain and swelling, decrease anxiety, relieve the suffering of victims of anxiety attacks and anxiety, and even deal with specific illness (such as epilepsy or Alzheimer’s). In addition, it has a really low toxicity and presents (practically) no addicting danger, even if the absence of clinical research studies minimizes these qualities to simple hypotheses.

Legalization of CBD in France: should we go further?

Definitely, the legal development concerning CBD is positive, but whatever remains to be done. The health ministry wants to be cautious, and the government’s position on the matter looks like a balancing act. At the same time, the National Medicines Agency has actually clearly spoken up. We therefore take care of the goat and the cabbage so as not to get too involved, while the vaporized cannabidiol has actually been offered in France for a couple of years currently, benefiting from the legal uncertainty that persists.

Beyond the 0.2% THC limit licensed in marketed products, it needs to be kept in mind that only the liquid kind of CBD (intended for electronic cigarettes) is really legal. The purchase and usage of resin or cigarette smoking herb is therefore not controlled, specifically considering that the THC level is often higher (around 15%). In addition, only using seeds and fibers is licensed in France. But what about CBD oil, which permits you to enjoy the advantages of the substance without exposing your lungs to possibly damaging smoke? What about CBD paste? On these topics, there is radio silence.

In addition, CBD is thought about a “dietary supplement”, which restricts presenting it as a medication. And make it an informed ad for users and clients. Regrettable, since, in the meantime, numerous prospective beneficiaries are not benefiting from it. It is therefore necessary to go further and clarify things: more than a concern of consumer welfare, it refers public health.

Scroll to top